封面
市場調查報告書
商品編碼
2075288

晶片實驗室和微陣列(生物晶片)市場:按類型、產品類型、應用、最終用戶和地區分類

Lab-on-a-chip and Microarrays (Biochip) Market, By Type, By Product, By Application, By End User, and By Geography -

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,晶片實驗室和微陣列(生物晶片)市場規模將達到 252.298 億美元,到 2033 年將達到 617.114 億美元。預計從 2026 年到 2033 年,該市場將以 13.6% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 252.298億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 13.60% 2033年市場規模預測: 617.114億美元

生物晶片是由排列在固體基板上的微小測試位點(微陣列)組成,它透過同時進行大量測試,實現高通量和高處理速度。一個生物晶片可以完成數千種生物反應。

市場動態:

慢性疾病負擔日益加重、對即時檢測的需求不斷成長、蛋白質組學和基因組學在癌症研究中的應用不斷擴大、個性化醫療的普及以及對微流體材料的需求不斷成長,預計這些因素將推動全球晶片實驗室和微陣列(生物晶片)市場的成長。

例如,2022年10月,MicrobioSeq(CD Genomics)宣布推出「全基因基因測序」服務,以支持生物標記的發現和非抗生素療法的開發。 CD Genomics利用次世代定序和長讀長定序技術提供病毒和噬菌體定序服務,以支持結構基因組學和比較基因組學的深入研究。

本研究的主要特點:

  • 本報告對全球晶片實驗室和微陣列(生物晶片)市場進行了詳細分析,提出了 2026 年至 2033 年預測期內的市場規模和複合年成長率 (CAGR%),其中 2025 年為基準年。
  • 此外,它還指出了每個細分市場的潛在商機,並說明了該市場中一個有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球晶片實驗室和微陣列(生物晶片)市場的主要公司概況。
  • 透過利用本報告中提出的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球晶片實驗室和微陣列(生物晶片)市場》報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用分析全球晶片實驗室和微陣列(生物晶片)市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 全球慢性病負擔日益加重
    • 替代技術的可用性
    • 蛋白質體學和基因體學的應用範圍不斷擴大
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 併購情景

第4章:全球晶片實驗室與微陣列(生物晶片)市場

  • 供給面和需求面分析
  • 經濟影響

第5章 全球晶片實驗室和微陣列(生物晶片)市場:按類型分類,2021-2033年

  • Lab-on-a-chip
  • 微陣列

第6章 全球晶片實驗室與微陣列(生物晶片)市場:依產品分類,2021-2033年

  • 裝置
  • 試劑和耗材
  • 軟體和服務

第7章 全球晶片實驗室與微陣列(生物晶片)市場:依應用領域分類,2021-2033年

  • 臨床診斷
  • 藥物發現
  • 基因組學和蛋白​​質組學
  • 其他用途

第8章 全球晶片實驗室和微陣列(生物晶片)市場:按最終用戶分類,2021-2033年

  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 學術研究機構

第9章 全球晶片實驗室和微陣列(生物晶片)市場:按地區分類,2021-2033年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地區

第10章 競爭格局

  • Merck KgaA
  • QIAGEN NV
  • BioMA(C)rieux
  • Illumina Inc.
  • Micronit BV
  • PerkinElmer Inc.
  • Thermo Fisher Scientific
  • Fluidigm Corporation
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Abbott Laboratories
  • Phalanx Biotech Group
  • Danaher Corporation(Cepheid)

第11章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI515

Lab-on-a-chip and Microarrays (Biochip) Market is estimated to be valued at USD 25,229.8 Mn in 2026 and is expected to reach USD 61,711.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 25,229.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 13.60% 2033 Value Projection: USD 61,711.4 Mn

A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that allow many tests to be performed at the same time to achieve high throughput and speed. A biochip can complete thousands of biological reactions.

Market Dynamics:

Rise in burden of chronic diseases, rise in demand for point-of-care testing, rise in application of proteomics and genomics in cancer research, increasing adoption of personalized medicines, and rise in demand for microfluidics materials are major factors expected to augment the growth of the global lab-on-a-chip and microarrays (biochip) market.

For instance, in October 2022, MicrobioSeq (CD Genomics) announced the launch of the Phage Whole-Genome Sequencing to help discover biomarkers and to develop non-antibiotic treatment methods. CD Genomics uses next-generation sequencing and long-read sequencing technologies to provide virus or phage sequencing services and help in-depth studies of structural genomics and comparative genomics.

Key features of the study:

  • The report provides in-depth analysis of the global lab-on-a-chip and microarrays (biochip) market, and provide market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2026-2033, considering 2025 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global lab-on-a-chip and microarrays (biochip) market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KgaA, QIAGEN NV, BioMerieux, Illumina Inc., Micronit, PerkinElmer Inc., Thermo Fisher Scientific, Fluidigm Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Abbott Laboratories, Phalanx Biotech Group, and Danaher Corporation (Cepheid), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global lab-on-a-chip and microarrays (biochip) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lab-on-a-chip and microarrays (biochip) market.

Detailed Segmentation:

  • Global Lab-on-a-chip and Microarrays (Biochip) Market, By Type (Revenue, USD Mn, 2021 - 2033)
  • Lab-on-a-chip
  • Microarray
  • Global Lab-on-a-chip and Microarrays (Biochip) Market, By Product (Revenue, USD Mn, 2021 - 2033)
  • Instruments
  • Reagents and Consumables
  • Software and Services
  • Global Lab-on-a-chip and Microarrays (Biochip) Market, By Application (Revenue, USD Mn, 2021 - 2033)
  • Clinical Diagnostics
  • Drug Discovery
  • Genomics and Proteomics
  • Other Application
  • Global Lab-on-a-chip and Microarrays (Biochip) Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Biotechnology
  • Pharmaceutical Companies
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Merck KgaA
  • QIAGEN NV
  • BioMerieux
  • Illumina Inc.
  • Micronit BV
  • PerkinElmer Inc.
  • Thermo Fisher Scientific
  • Fluidigm Corporation
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Abbott Laboratories
  • Phalanx Biotech Group
  • Danaher Corporation (Cepheid)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of chronic diseases worldwide
    • Availability of alternative technologies
    • Rise in application of proteomics and genomics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Merger and Acquisition Scenario

4. Global Lab-on-a-chip and Microarrays (Biochip) Market

  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Lab-on-a-chip
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Product, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Reagents and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Application, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Genomics and Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Other Application
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

8. Global Lab-on-a-chip and Microarrays (Biochip) Market, By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Hospitals and Diagnostics Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

9. Global Lab-on-a-chip and Microarrays (Biochip) Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

10. Competitive Landscape

  • Merck KgaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioMA(C)rieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Micronit BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fluidigm Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phalanx Biotech Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Cepheid)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us